Clinical Trials: Sarcoma

Arkansas

Little Rock; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

California

Duarte; City of Hope
COG ARST0332: Risk Based Treatment for Pediatric Non Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS)

Duarte; City of Hope
Phase II Study of Preoperative Intensity-Modulated Radiation Therapy for Soft-Tissue Sarcomas

Duarte; City of Hope
COG #AEWS0331: European Ewing Tumour Working Initiative of National Groups Ewing Tumor Studies 1999 (EURO-E-W.I.N.G. 99)

Duarte; City of Hope
SARC 011, N021157: SARC Global Collaboration: Phase II Trial of R1507, A Recombinant Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Osteosarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas

Duarte; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Duarte; City of Hope
A Phase 1b/2 Study of AMG 655 in Combination with Doxorubicin for the First-Line Treatment of Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma

Duarte; City of Hope
SARC-009: A Phase II Trial of Dasantinib in Advanced Sarcoma

Duarte; City of Hope
COG#ARST0531: Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) versus VAC Alternating with Vincristine and Irinotecan (VI) for Patients with Intermediate-Risk Rhabdomyosarcoma (RMS) - A Groupwide Phase III Study

Duarte; City of Hope
A Pivotal Trial to Determine the Efficacy and Safety of AP23573 When Administered as Maintenance Therapy to Patients with Metastatic Soft Tissue or Bone Sarcomas

Duarte; City of Hope
A Phase I/II Study of Nelfinavir in Liposarcoma

Los Angeles; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Santa Monica; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Stanford; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

West Hollywood; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Florida

Gainesville; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Tampa; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Georgia

Atlanta; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Idaho

Coeur D'Alene; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Maryland

Baltimore; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Bethesda; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Massachusetts

Boston; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Michigan

Ann Arbor; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Minnesota

Rochester; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Nebraska

Omaha; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

New York

Bronx; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

New York; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

New York; Columbia-Presbyterian Medical Center
A phase II study of escalating doses of infusional single agent epirubicin hydrochloride (Ellence™) for treatment of advanced soft tissue sarcoma, with correlative studies of cardiac toxicity, tissue analysis for multidrug resistance (MDR), and evaluation of MDR by technetium-99m MIBI SPECT

New York; Columbia Presbyterian
A Phase II Clinical Trial of Alimta Plus Gemcitabine as Chemotherapy for Patients with Advanced Sarcoma

New York; Columbia Presbyterian
A Multicenter, OpenLabel SingleArm Study of YONDELIS (trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment.

North Carolina

Charlotte; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Ohio

Cleveland; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Oregon

Portland; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Pennsylvania

Philadelphia; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Tennessee

Nashville; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Texas

Houston; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Houston; S. R. Burzynski Clinic
Phase II Study Of Antineoplastons A10 And AS2-1 In Patients With Soft Tissue Sarcoma

Utah

Salt Lake City; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Washington

Seattle; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Washington, DC

Washington; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

International

Melbourne, Australia; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Sydney, Australia; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Westmead, Australia; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Vancouver, BC, Canada; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Bordeaux, France; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Lille, France; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Lille, France; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Lyon, France; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Lyon, France; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Marseille, France; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Marseille, France; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Nantes, France; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Paris, France; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Paris, France; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Toulouse, France; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Villejuif, France; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Villejuif, France; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Bad Saarow, Germany; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Frankfurt Am Main, Germany; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Mannheim, Germany; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Munster, Germany; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Tübingen, Germany; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Bologna, Italy; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Genova, Italy; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Milano, Italy; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Milano, Italy; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Padova, Italy; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Amsterdam, Netherlands; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Rotterdam, Netherlands; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Rotterdam, Netherlands; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Oslo, Norway; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Barcelona, Spain; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Madrid, Spain; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Palma de Mallorca, Spain; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Lund, Sweden; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Stockholm, Sweden; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Birmingham, United Kingdom; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Birmingham, United Kingdom; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Bristol, United Kingdom; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Glasgow, United Kingdom; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Leeds, United Kingdom; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

London, United Kingdom; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

London, United Kingdom; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Manchester, United Kingdom; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Manchester, United Kingdom; Research Site:
A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Newcastle upon Tyne, United Kingdom; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

Surrey, United Kingdom; Research Site:
A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.